26,612 Shares in The Cooper Companies, Inc. $COO Acquired by Eurizon Capital SGR S.p.A.

Eurizon Capital SGR S.p.A. acquired a new position in shares of The Cooper Companies, Inc. (NASDAQ:COO) in the 4th quarter, according to the company in its most recent filing with the SEC. The fund acquired 26,612 shares of the medical device company’s stock, valued at approximately $2,183,000.

Several other large investors have also recently modified their holdings of the company. Capital World Investors raised its stake in shares of Cooper Companies by 25.7% during the 3rd quarter. Capital World Investors now owns 10,551,592 shares of the medical device company’s stock worth $723,417,000 after acquiring an additional 2,159,233 shares in the last quarter. State Street Corp raised its stake in shares of Cooper Companies by 1.2% during the 2nd quarter. State Street Corp now owns 8,659,741 shares of the medical device company’s stock worth $616,227,000 after acquiring an additional 104,910 shares in the last quarter. Wellington Management Group LLP raised its stake in shares of Cooper Companies by 332.9% during the 3rd quarter. Wellington Management Group LLP now owns 6,184,992 shares of the medical device company’s stock worth $424,043,000 after acquiring an additional 4,756,178 shares in the last quarter. Sustainable Growth Advisers LP raised its stake in shares of Cooper Companies by 22.1% during the 3rd quarter. Sustainable Growth Advisers LP now owns 4,132,535 shares of the medical device company’s stock worth $283,327,000 after acquiring an additional 747,476 shares in the last quarter. Finally, Ameriprise Financial Inc. raised its stake in shares of Cooper Companies by 98.8% during the 2nd quarter. Ameriprise Financial Inc. now owns 3,388,413 shares of the medical device company’s stock worth $241,120,000 after acquiring an additional 1,683,561 shares in the last quarter. Institutional investors own 24.39% of the company’s stock.

Analyst Ratings Changes

COO has been the topic of a number of recent analyst reports. Citigroup restated a “neutral” rating and set a $69.00 price target (down from $80.00) on shares of Cooper Companies in a research note on Thursday, May 28th. Wall Street Zen upgraded shares of Cooper Companies from a “hold” rating to a “buy” rating in a research note on Saturday, February 28th. Barclays upped their price target on shares of Cooper Companies from $98.00 to $103.00 and gave the company an “overweight” rating in a research note on Friday, March 6th. The Goldman Sachs Group set a $61.00 price target on shares of Cooper Companies in a research note on Wednesday, May 27th. Finally, Rothschild & Co Redburn lowered shares of Cooper Companies from a “buy” rating to a “neutral” rating and set a $85.00 price target on the stock. in a research note on Wednesday, March 4th. One research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $88.07.

Cooper Companies Trading Down 1.2%

Shares of Cooper Companies stock opened at $59.49 on Wednesday. The company has a current ratio of 1.34, a quick ratio of 0.79 and a debt-to-equity ratio of 0.22. The Cooper Companies, Inc. has a 12-month low of $58.89 and a 12-month high of $89.83. The firm has a market capitalization of $11.61 billion, a price-to-earnings ratio of 29.45, a PEG ratio of 1.55 and a beta of 0.87. The firm’s 50 day simple moving average is $65.75 and its two-hundred day simple moving average is $74.81.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings data on Thursday, March 5th. The medical device company reported $1.10 earnings per share for the quarter, topping analysts’ consensus estimates of $1.03 by $0.07. The firm had revenue of $1.02 billion for the quarter, compared to analyst estimates of $1.02 billion. Cooper Companies had a net margin of 9.67% and a return on equity of 10.34%. The business’s quarterly revenue was up 6.2% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.92 earnings per share. Cooper Companies has set its Q2 2026 guidance at 4.580-4.660 EPS. Analysts predict that The Cooper Companies, Inc. will post 4.62 EPS for the current year.

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.